Literature DB >> 22712567

Hemostasis parameters disturbances in healthy individuals with prehypertension.

Dimitris Papadopoulos1, Iordanis Mourouzis, Athanasia Kotrotsou, Urania Papazachou, Elias Sanidas, Kostas Tsioufis, Thomas Makris.   

Abstract

Prehypertension (PH) seems to be related to increased cardiovascular risk in healthy normotensive subjects, while essential hypertension is associated with hemostasis balance disturbances. The aim of our study was to examine the impact of PH on hemostasis parameters in healthy individuals with PH and to compare the findings with those of healthy normotensives with normal blood pressure (NBP) levels. This study was performed in 204 (96 M, 108 F) subjects who attended our hypertension clinic. Seventy-eight (36 M, 42 F) subjects with PH, mean age 52 ± 5 years, and body mass index (BMI) 23 ± 1.5 kg/m2 made up group A, and 126 (60 M, 66 F) subjects with NBP, mean age 53 ± 6 years, and BMI 23.2 ± 1.4 kg/m2 without any history of cardiovascular disease or diabetes mellitus made up group B. Systolic blood pressure and diastolic blood pressure were measured in three sequential visits, which were performed by the same trained nurse. Serum lipid levels, fibrinogen (F), thrombomodulin (TM), and plasminogen activator inhibitor-1 antigen, and tissue plasminogen activator antigen were determined in the whole population. Plasminogen activator inhibitor-1 antigen and tissue plasminogen activator antigen levels were significantly higher in the PH group as compared with normotensives, while in PH subjects, significantly higher plasma levels of F and TM were found compared with normotensive group. The two groups were matched for age, sex, BMI, and serum lipid levels. Our findings indicate that PH is associated with hemostasis disturbances predisposing to hypercoagulability and impaired fibrinolysis. This observation may be of prognostic value for future cardiovascular events in this group and needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22712567     DOI: 10.3109/10641963.2011.631650

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  3 in total

1.  It is time to contend with the endothelial consequences of prehypertension.

Authors:  G P Van Guilder
Journal:  J Hum Hypertens       Date:  2015-01-08       Impact factor: 3.012

2.  PAI-1 Inhibition - Another Therapeutic Option for Cardiovascular Protection.

Authors:  Monica Mariana Baluta; Marius Marcian Vintila
Journal:  Maedica (Buchar)       Date:  2015-06

3.  Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: the effect of treatment with an angiotensin II receptor blocker.

Authors:  E Gavriilaki; E Gkaliagkousi; B Nikolaidou; G Triantafyllou; F Chatzopoulou; S Douma
Journal:  J Hum Hypertens       Date:  2014-03-13       Impact factor: 3.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.